Digital Therapeutics Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030

The global Digital Therapeutics market size is expected to be worth around US$ 29.1 billion by 2030, according to a new report by Vision Research Reports.

The global Digital Therapeutics market size was valued at US$ 13.5 billion in 2020 and is anticipated to grow at a CAGR of 33.1% during forecast period 2021 to 2030.

Growth Factors

 The key drivers for this growth include increasing incidence of chronic diseases, digitization, demand for innovative and affordable healthcare, and government initiatives.

Digital health went from novel to necessity during 2020. It swept through almost every healthcare domain as adoption peaked, accelerated by the COVID-19 pandemic. This included telehealth, telemedicine, digital pathology, triage solutions, mhealth, as well as digital therapeutics. Omada Health, Inc., a digital therapeutics provider, leveraged the gaps in care due to COVID-19 to provide extra support and guidance from its licensed specialists to those who had their doctor’s appointments deferred indefinitely. The company also helped primary care providers, therapists, endocrinologists, and cardiologists convert their practices to telehealth through enhanced education, psychosocial support, and remote monitoring.

In response to COVID-19 and its repercussions on mental health, the FDA released guidelines expanding and promoting the scope of digital health therapeutic devices for mental health conditions. Rising initiatives by public and private players is another factor expected to propel the market growth. For instance, in June 2020, Akili Interactive Labs, Inc. received the CE mark for its digital therapeutic software for the treatment of ADHD called EndeavorRx.

With an increase in internet usage and dependency on smartphones, digital therapeutics is set to register continued growth over the forecast period. This is owing to increased demand for creative and innovative treatment options that could be used remotely by patients. In February 2021, SilverCloud partnered with Cerner Corporation to integrate its virtual mental health platform with the latter’s electronic health records. With this, SilverCloud intended to scale the delivery of evidence-based mental health treatment while improving patient outcomes and lowering the cost of care.

Report Highlights

The diabetes segment dominated the market for digital therapeutics and held the largest revenue share of more than 28.0% in 2020. The segment is expected to record the fastest growth during the forecast period. This growth is driven by the rising incidence of diabetes in the global population. According to the International Diabetes Federation (IDF), 463 million people were living with diabetes in 2019 and this number is expected to reach 700 million by 2045. This is estimated to boost demand for related digital therapeutics solutions. For instance, Patients suffering from diabetes require effective management, coaching, and guidance to handle symptoms like polyuria, polydipsia, and polyphagia, and medication reminders.

The obesity segment is anticipated to grab the second-largest share of the market. As per CDC’s National Center for Health Statistics prevalence of obesity in the U.S. was 42.4% in 2017 and 2018. This growing number is expected to fuel segment growth.

The patients segment dominated the market for digital therapeutics and held the largest revenue share of more than 32.0% in 2020 and is expected to register the highest CAGR during the forecast period. Patients are the primary users of therapeutic healthcare applications and programs. With the burgeoning number of patients suffering from chronic conditions, the demand for digital therapeutics is increasing.

Growth of the providers segment, on the other hand, can be attributed to more and more providers leveraging digital therapeutics to deliver and support therapies that are clinically proven, outside of a care setting, in addition to providing reliable patient engagement. Payers are also getting increasingly interested in covering digital therapeutics, and the segment has much scope for growth. Payers are encouraged to take initiatives by business models that facilitate adherence and enhance efficacy while reducing costs.

North America held the dominant share of more than 41.0% in the digital therapeutics market in 2020. This growth is attributed to the presence of key players, rising government initiatives, well-developed healthcare infrastructure, and rising prevalence of chronic health issues.

In April 2020, the U.S. FDA released guidelines to expand the availability of digital health therapeutic devices for psychiatric conditions. With this, the FDA intended to support individuals that were following home quarantine orders or practicing social distancing, without the need for in-clinic visits during the COVID-19 public health emergency. This would also ease burdens on healthcare facilities and reduce the risk of exposure to the virus.

In Asia Pacific, the market is expected to register the fastest growth rate over the forecast period, owing to two major factors: a large and comparatively younger population base that converts into a vast target base and rapid urbanization and digitization. In addition, constant reforms in countries to address the lack of proper infrastructure and maintain sustainable growth through financial inclusion are expected to benefit the market. As per India Cellular and Electronics Association 2020 report, 97.0% of the internet users across the country access the internet through mobile devices due to factors such as reduced smartphone prices, increased affordability of mobile data, rise in the number of rural users, and various Government initiatives.

Key Players

  • Omada Health, Inc.

  • WellDoc, Inc.

  • 2Morrow, Inc.

  • Livongo Health

  • Propeller Health

  • Pear Therapeutics

  • Twine Health, Inc.

  • Canary Health, Inc.

  • Noom Health, Inc.

  • Mango Health, Inc.

Market Segmentation

  • Application Outlook 

    • Diabetes

    • Obesity

    • CVD

    • CNS Disease

    • Respiratory Diseases

    • Smoking Cessation

    • Others

  • End-use Outlook

    • Patients

    • Providers

    • Payers

    • Employers

    • Others

  •  Regional Outlook 

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

    • Asia Pacific

      • China

      • India

      • Japan

    • Latin America

      • Brazil

      • Mexico

      • Argentina

    • MEA

      • South Africa

      • Saudi Arabia

The Digital Therapeutics market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report provides size (in terms of volume and value) of Digital Therapeutics market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global Digital Therapeutics market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Digital Therapeutics market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted Digital Therapeutics market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

In terms of production side, this report researches the Digital Therapeutics capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.

In terms of consumption side, this report focuses on the consumption of Digital Therapeutics by regions (countries) and application.

Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Digital Therapeutics market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Digital Therapeutics market companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Digital Therapeutics market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the Digital Therapeutics industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

The Digital Therapeutics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Digital Therapeutics market.

Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Digital Therapeutics market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.

Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Digital Therapeutics market. These factors have benefited the growth of the global market for Digital Therapeutics. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.

New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Digital Therapeutics. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).

In this study, the years considered to estimate the market size of Digital Therapeutics are as follows:

  • Historic Year: 2017-2020
  • Base Year: 2021
  • Forecast Year 2021 to 2030

Reasons to Purchase this Report:

- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Market Size Estimation

Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).

The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.

Secondary Sources

Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.

Primary Sources

 In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Table oc Content

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape List of Suppliers List of Buyers

Chapter 7. Global Digital Therapeutics Market, By End User

7.1. Digital Therapeutics Market, by End User Type, 2020-2030

7.1.1. Patients Market Revenue and Forecast (2016-2030)

7.1.2. Providers Market Revenue and Forecast (2016-2030)

7.1.3. Payers Market Revenue and Forecast (2016-2030)

7.1.4. Employers Market Revenue and Forecast (2016-2030)

7.1.5. Others Market Revenue and Forecast (2016-2030)

Chapter 8. Global Digital Therapeutics Market, By Application

8.1. Digital Therapeutics Market, by Application, 2020-2030

8.1.1. Diabetes Market Revenue and Forecast (2016-2030)

8.1.2. Obesity Market Revenue and Forecast (2016-2030)

8.1.3. CVD Market Revenue and Forecast (2016-2030)

8.1.4. CNS Disease Market Revenue and Forecast (2016-2030)

8.1.5. Respiratory Diseases Market Revenue and Forecast (2016-2030)

8.1.6. Smoking Cessation Market Revenue and Forecast (2016-2030)

8.1.7. Others Market Revenue and Forecast (2016-2030)

Chapter 9. Global Digital Therapeutics Market, Regional Estimates and Trend Forecast

9.1. North America

9.1.1. Market Revenue and Forecast, by End User (2016-2030)

9.1.2. Market Revenue and Forecast, by Application (2016-2030)

9.1.3. U.S. Market Revenue and Forecast, by End User (2016-2030) Market Revenue and Forecast, by Application (2016-2030)

9.1.4. Rest of North America Market Revenue and Forecast, by End User (2016-2030) Market Revenue and Forecast, by Application (2016-2030)

9.2. Europe

9.2.1. Market Revenue and Forecast, by End User (2016-2030)

9.2.2. Market Revenue and Forecast, by Application (2016-2030)

9.2.3. UK Market Revenue and Forecast, by End User (2016-2030) Market Revenue and Forecast, by Application (2016-2030)

9.2.4. Germany Market Revenue and Forecast, by End User (2016-2030) Market Revenue and Forecast, by Application (2016-2030)

9.2.5. France Market Revenue and Forecast, by End User (2016-2030) Market Revenue and Forecast, by Application (2016-2030)

9.2.6. Rest of Europe Market Revenue and Forecast, by End User (2016-2030) Market Revenue and Forecast, by Application (2016-2030)

9.3. APAC

9.3.1. Market Revenue and Forecast, by End User (2016-2030)

9.3.2. Market Revenue and Forecast, by Application (2016-2030)

9.3.3. India Market Revenue and Forecast, by End User (2016-2030) Market Revenue and Forecast, by Application (2016-2030)

9.3.4. China Market Revenue and Forecast, by End User (2016-2030) Market Revenue and Forecast, by Application (2016-2030)

9.3.5. Japan Market Revenue and Forecast, by End User (2016-2030) Market Revenue and Forecast, by Application (2016-2030)

9.3.6. Rest of APAC Market Revenue and Forecast, by End User (2016-2030) Market Revenue and Forecast, by Application (2016-2030)

9.4. MEA

9.4.1. Market Revenue and Forecast, by End User (2016-2030)

9.4.2. Market Revenue and Forecast, by Application (2016-2030)

9.4.3. GCC Market Revenue and Forecast, by End User (2016-2030) Market Revenue and Forecast, by Application (2016-2030)

9.4.4. North Africa Market Revenue and Forecast, by End User (2016-2030) Market Revenue and Forecast, by Application (2016-2030)

9.4.5. South Africa Market Revenue and Forecast, by End User (2016-2030) Market Revenue and Forecast, by Application (2016-2030)

9.4.6. Rest of MEA Market Revenue and Forecast, by End User (2016-2030) Market Revenue and Forecast, by Application (2016-2030)

9.5. Latin America

9.5.1. Market Revenue and Forecast, by End User (2016-2030)

9.5.2. Market Revenue and Forecast, by Application (2016-2030)

9.5.3. Brazil Market Revenue and Forecast, by End User (2016-2030) Market Revenue and Forecast, by Application (2016-2030)

9.5.4. Rest of LATAM Market Revenue and Forecast, by End User (2016-2030) Market Revenue and Forecast, by Application (2016-2030)

Chapter 10. Company Profiles

10.1. Omada Health, Inc.

10.1.1. Company Overview

10.1.2. Product Offerings

10.1.3. Financial Performance

10.1.4. Recent Initiatives

10.2. WellDoc, Inc.

10.2.1. Company Overview

10.2.2. Product Offerings

10.2.3. Financial Performance

10.2.4. Recent Initiatives

10.3. 2Morrow, Inc

10.3.1. Company Overview

10.3.2. Product Offerings

10.3.3. Financial Performance

10.3.4. Recent Initiatives

10.4. Livongo Health

10.4.1. Company Overview

10.4.2. Product Offerings

10.4.3. Financial Performance

10.4.4. Recent Initiatives

10.5. Propeller Health

10.5.1. Company Overview

10.5.2. Product Offerings

10.5.3. Financial Performance

10.5.4. Recent Initiatives

10.6. Pear Therapeutics

10.6.1. Company Overview

10.6.2. Product Offerings

10.6.3. Financial Performance

10.6.4. Recent Initiatives

10.7. Twine Health, Inc.

10.7.1. Company Overview

10.7.2. Product Offerings

10.7.3. Financial Performance

10.7.4. Recent Initiatives

10.8. Canary Health, Inc.

10.8.1. Company Overview

10.8.2. Product Offerings

10.8.3. Financial Performance

10.8.4. Recent Initiatives

10.9. Noom Health, Inc.

10.9.1. Company Overview

10.9.2. Product Offerings

10.9.3. Financial Performance

10.9.4. Recent Initiatives

10.10. Mango Health, Inc.

10.10.1. Company Overview

10.10.2. Product Offerings

10.10.3. Financial Performance

10.10.4. Recent Initiatives

Chapter 11. Research Methodology

11.1. Primary Research

11.2. Secondary Research

11.3. Assumptions

Chapter 12. Appendix

12.1. About Us

12.2. Glossary of Terms

Report Detail

Proceed To Buy

USD 3500
USD 7000